Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Ling

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Analytical Chemistry|June 11, 2020
Universal Sample Preparation Unlocking Multimodal Molecular Tissue ImagingAndreas Dannhorn, Emine Kazanc, Stephanie Ling, et al.
Disease Models & Mechanisms|February 28, 2025
Use of metabolic imaging to monitor heterogeneity of tumour response following therapeutic mTORC1/2 pathway inhibitionStephanie Ling, Alex Dexter, Alan M Race, et al.
Journal of the American Society for Mass Spectrometry|November 25, 2025
Automatic Tissue Detection for Mass Spectrometry ImagingJames Denholm, Lucy E Flint, Jack Richings, et al.
Kidney International|March 2, 2024
Multi-omics and imaging mass cytometry characterization of human kidneys to identify pathways and phenotypes associated with impaired kidney functionEvans O Asowata, Simone Romoli, Rebecca Sargeant, et al.
Journal of the American Society for Mass Spectrometry|November 12, 2021
Holistic Characterization of a <i>Salmonella</i> Typhimurium Infection Model Using Integrated Molecular ImagingNicole Strittmatter, Panchali Kanvatirth, Paolo Inglese, et al.
Molecular Cancer Therapeutics|September 20, 2019
Pharmacology of the ATM Inhibitor AZD0156: Potentiation of Irradiation and Olaparib Responses PreclinicallyLucy C Riches, Antonio G Trinidad, Gareth Hughes, et al.
Nature Communications|July 16, 2024
Metabolic imaging across scales reveals distinct prostate cancer phenotypesNikita Sushentsev, Gregory Hamm, Lucy Flint, et al.
Nature Communications|November 9, 2019
AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activityJacqueline H L Fok, Antonio Ramos-Montoya, Mercedes Vazquez-Chantada, et al.
Analytical Chemistry|January 10, 2022
Method To Visualize the Intratumor Distribution and Impact of Gemcitabine in Pancreatic Ductal Adenocarcinoma by Multimodal ImagingNicole Strittmatter, Frances M Richards, Alan M Race, et al.
Science Advances|June 26, 2018
The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor modelsStephen T Durant, Li Zheng, Yingchun Wang, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Analytical Chemistry|June 11, 2020
Universal Sample Preparation Unlocking Multimodal Molecular Tissue ImagingAndreas Dannhorn, Emine Kazanc, Stephanie Ling, et al.
Disease Models & Mechanisms|February 28, 2025
Use of metabolic imaging to monitor heterogeneity of tumour response following therapeutic mTORC1/2 pathway inhibitionStephanie Ling, Alex Dexter, Alan M Race, et al.
Journal of the American Society for Mass Spectrometry|November 25, 2025
Automatic Tissue Detection for Mass Spectrometry ImagingJames Denholm, Lucy E Flint, Jack Richings, et al.
Kidney International|March 2, 2024
Multi-omics and imaging mass cytometry characterization of human kidneys to identify pathways and phenotypes associated with impaired kidney functionEvans O Asowata, Simone Romoli, Rebecca Sargeant, et al.
Journal of the American Society for Mass Spectrometry|November 12, 2021
Holistic Characterization of a <i>Salmonella</i> Typhimurium Infection Model Using Integrated Molecular ImagingNicole Strittmatter, Panchali Kanvatirth, Paolo Inglese, et al.
Molecular Cancer Therapeutics|September 20, 2019
Pharmacology of the ATM Inhibitor AZD0156: Potentiation of Irradiation and Olaparib Responses PreclinicallyLucy C Riches, Antonio G Trinidad, Gareth Hughes, et al.
Nature Communications|July 16, 2024
Metabolic imaging across scales reveals distinct prostate cancer phenotypesNikita Sushentsev, Gregory Hamm, Lucy Flint, et al.
Nature Communications|November 9, 2019
AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activityJacqueline H L Fok, Antonio Ramos-Montoya, Mercedes Vazquez-Chantada, et al.
Analytical Chemistry|January 10, 2022
Method To Visualize the Intratumor Distribution and Impact of Gemcitabine in Pancreatic Ductal Adenocarcinoma by Multimodal ImagingNicole Strittmatter, Frances M Richards, Alan M Race, et al.
Science Advances|June 26, 2018
The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor modelsStephen T Durant, Li Zheng, Yingchun Wang, et al.
Pageof 3